You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Somerset Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for SOMERSET, and what generic and branded alternatives to SOMERSET drugs are available?

SOMERSET has thirty-five approved drugs.



Summary for Somerset
US Patents:0
Tradenames:31
Ingredients:28
NDAs:35

Drugs and US Patents for Somerset

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Somerset CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 217689-002 Oct 19, 2023 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Somerset Theraps Llc BIMATOPROST bimatoprost SOLUTION/DROPS;OPHTHALMIC 207601-001 Jun 19, 2019 AT RX No No ⤷  Try a Trial ⤷  Try a Trial
Somerset Theraps Llc CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 206791-002 Feb 20, 2019 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Somerset Theraps Llc ISOSULFAN BLUE isosulfan blue INJECTABLE;INJECTION 210558-001 Jul 12, 2019 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Somerset DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 207523-001 Jun 25, 2019 AT1 RX No No ⤷  Try a Trial ⤷  Try a Trial
Somerset Theraps Llc PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride SOLUTION;OPHTHALMIC 210384-002 Nov 25, 2019 AT RX No No ⤷  Try a Trial ⤷  Try a Trial
Somerset Theraps Llc ROPIVACAINE HYDROCHLORIDE ropivacaine hydrochloride SOLUTION;INJECTION 207636-001 Jun 15, 2018 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Somerset

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 RE34579 ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006 7,070,808 ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 7,150,881 ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 7,150,881 ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 7,070,808 ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 7,638,140 ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 RE34579 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.